Effect of dignity therapy on end-of-life psychological distress in terminally ill Portuguese patients: A randomized controlled trial by Fareleira, Miguel António Costa Bandeira Arez Julião et al.
Effect of dignity therapy on end-of-life psychological
distress in terminally ill Portuguese patients: A
randomized controlled trial
MIGUEL JULIA˜O, M.D., M.SC., PH.D.,1 FA´TIMA OLIVEIRA, R.N.,2 BALTAZAR NUNES, PH.D.,3
ANTO´NIO VAZ CARNEIRO, M.D., PH.D.,4 AND ANTO´NIO BARBOSA, M.D., PH.D.5
1Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal
2Department of Palliative Medicine, Instituto das Irma˜s Hospitaleiras do Sagrado Corac¸a˜o de Jesus, Casa de Sau´de da
Idanha, Belas, Portugal
3Department of Epidemiology, Instituto Dr. Ricardo Jorge, Lisbon, Portugal
4Center for Evidence-Based Medicine, Faculty of Medicine of the University of Lisbon, Lisbon, Portugal
5Center for Bioethics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
(RECEIVED March 18, 2016; ACCEPTED January 26, 2017)
ABSTRACT
Objective: Dignity therapy (DT) is a brief form of psychotherapy developed for patients living
with a life-limiting illness that has demonstrated efficacy in treating several dimensions of end-
of-life psychological distress. Our aim was to determine the influence of DT on demoralization
syndrome (DS), the desire for death (DfD), and a sense of dignity (SoD) in terminally ill
inpatients experiencing a high level of distress in a palliative care unit.
Method: A nonblinded phase II randomized controlled trial was conducted with 80 patients
who were randomly assigned to one of two groups: the intervention group (DT þ standard
palliative care [SPC]) or the control group (SPC alone). The main outcomes were DS, DfD, and
SoD, as measured according to DS criteria, the Desire for Death Rating Scale, and the Patient
Dignity Inventory (PDI), respectively. All scales were assessed at baseline (day 1) and at day 4 of
follow-up. This study is registered with http://www.controlled-trials.com/ISRCTN34354086.
Results: Of the 80 participants, 41 were randomized to DT and 39 to SPC. Baseline
characteristics were similar between the two groups. DT was associated with a significant
decrease in DS compared with SPC (DT DS prevalence ¼ 12.1%; SPC DS prevalence ¼ 60.0%;
p , 0.001). Similarly, DT was associated with a significant decrease in DfD prevalence (DT DfD
prevalence ¼ 0%; SPC DfD prevalence ¼ 14.3%; p ¼ 0.054). Compared with participants
allocated to the control group, those who received DT showed a statistically significant reduction
in 19 of 25 PDI items.
Significance of results: Dignity therapy had a beneficial effect on the psychological distress
encountered by patients near the end of life. Our research suggests that DT is an important
psychotherapeutic approach that should be included in clinical care programs, and it could help
more patients to cope with their end-of-life experiences.
KEYWORDS: Dignity therapy, End-of-life psychological distress, Randomized controlled trial,
Palliative care
INTRODUCTION
Patients with life-threatening illnesses face great
psychological challenges and frequently experience
a high prevalence of emotional distress, including de-
pression and anxiety (Block, 2001). It is becoming in-
creasingly clear that there are other significant
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forms and expressions of patient suffering toward the
end of life (Block, 2000; Julia˜o, 2014). This end-of-life
psychological experience includes such constructs as
demoralization syndrome (DS), the desire for death
(DfD), and a loss of dignity (Julia˜o, 2014).
Demoralization is a common psychiatric disorder
associated with the end of life and has been com-
monly observed in the medically and psychiatrically
ill. Hopelessness, helplessness, and the loss of pur-
pose and meaning in life—the loss of morale—are
key and central symptoms of DS. This psychological
construct is associated with chronic medical ill-
nesses, disabilities, bodily disfigurement, loss of dig-
nity, social isolation, feelings of greater dependency
on others, and/or the perception of being a burden
(Kissane et al., 2001).
Various studies have addressed the issue of DfD
and requests for euthanasia and physician-assisted
suicide among terminally ill patients (Chochinov
et al., 1995; Breitbart et al., 2000; Mystakidou
et al., 2005). The evidence shows that DfD is associ-
ated with complex and multifactorial factors, and so-
cial and psychological variables, such as depression,
pain, and physical functioning, as well as deteriora-
tion in quality of life and loss of dignity (Hudson
et al, 2006).
Psychological suffering for terminally ill patients
is also often framed in terms of loss of dignity (Cho-
chinov, 2007). Dignity can be defined as the quality
of being worthy of honor or respect. The concept of
dignity was always one of the central aspects of med-
icine. To think about the modern concept of dignity in
its many different aspects is an imperative of modern
medicine. This concept has been an integral part of
human life and culture since ancient times, integrat-
ing our life experiences, victories, and sufferings.
However, despite being an inalienable aspect of every
human being, something that belongs to every indi-
vidual, dignity has also been somewhat foreign to
our individual and collective consciousness. Over
the last 20 years, there has been a significant scien-
tific investment in the clarification and implementa-
tion within the field of medicine of the often vague
and misused concept of dignity, especially in pallia-
tive medicine and through working with patients at
the end of their lives (Julia˜o, 2015). The empirical
work by Chochinov and colleagues (2002) regarding
the concept of dignity in terminally ill patients led
to the creation of their Model of Dignity, which of-
fered important insights into how patients face ter-
minal illness in terms of illness-, social-, and
personal-related factors, which might empower or
undermine one’s sense of dignity (SoD). This model
was the basis for the creation of dignity therapy
(DT), a brief individualized intervention designed
to address psychosocial and existential distress
among terminally ill patients (Chochinov et al.,
2005).
Previous trials were designed to study DT’s effi-
cacy with respect to end-of-life distress compared
with standard palliative care (SPC) and other inter-
ventions (Hall et al., 2011; Chochinov et al., 2011; Ju-
lia˜o et al., 2013a; 2014). Chochinov and coworkers
(2011) compared DT with SPC and a client-centered
intervention and found that, although DT did not sig-
nificantly reduce distress, those assigned to DT were
significantly more likely than those in other study
groups to find this approach helpful, to report im-
proved quality of life, an increased SoD, and a change
in how their family saw and appreciated them. While
DT did not demonstrate any effect on depression and
anxiety, the authors stated that this was likely due to
the low baseline rates of distress. For this reason, Ju-
lia˜o et al. (2013a; 2014) conducted a randomized con-
trolled trial (RCT) that targeted more distressed
patients. They found that DT outperformed SPC
and significantly ameliorated both depression and
anxiety.
In the RCT by Julia˜o (2014), other psychosocial
variables were studied, including DS, DfD, and
SoD. The present paper reports the findings of our
comparison of how DT and SPC affect DS, DfD, and
SoD in a cohort of 80 terminally ill patients who
were being cared for in a Portuguese palliative care
unit.
METHODS
This phase II nonblinded RCT comprised two study
arms: an intervention group (DT plus SPC) and a con-
trol group (SPC alone). Given the nature of the study
design, it was not possible for the investigators or pa-
tients to be blinded to study arm assignment (http://
www.controlled-trials.com/ISRCTN34354086).
Participants
Recruitment took place from the S. Bento Menni ter-
tiary inpatient palliative medicine unit in Lisbon
over the course of 36 months (May of 2010 to May
of 2013). The inclusion criteria were as follows: being
18 years of age; having a life-threatening disease
with a prognosis of 6 months or less; showing no evi-
dence of dementia or delirium (as determined by
chart review or clinical consensus); a Mini-Mental
State score 20; having the ability to read and speak
Portuguese and provide written informed consent;
and being available for four to five research encoun-
ters over the period of a month. The study was ap-
proved by the Ethics Committee of the Instituto das
Irma˜s Hospitaleiras do Sagrado Corac¸a˜o de Jesus
Julia˜o et al.2
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and the Ethics Committee of the Faculty of Medicine
at the University of Lisbon.
Randomization and Masking
The randomization process was computer-generated,
using a fixed block of four, and was conducted by an
independent statistician. The selection process did
not take into account patients’ background vari-
ables—namely, levels of psychological distress at
baseline. Allocation concealment was achieved using
sequentially numbered envelopes for consecutive
trial participants. After baseline measures were ob-
tained by the secondary investigator (a trained
nurse, F.O.), the envelope was opened in the presence
of the patient to reveal to which study arm they had
been assigned. While the principal investigator
(M.J.) was not blind to patients’ arm assignments,
he was blind to the psychometric results throughout
the entire protocol. The secondary investigator was
blind to the content of DT sessions.
Interventions
Standard Palliative Care
SPC was provided by a multiprofessional palliative
care team comprised of three palliative care physi-
cians (one of whom was M.J.), nurses, a psychologist,
a social worker, and a spiritual assistant, thus being
well poised to meet the physical, existential, and psy-
chosocial needs of patients and families, meeting
once daily, in patients’ individual rooms. Clinical
care included regular clinical follow-up: physical ex-
amination, symptom assessment and management,
and clinical interviews (median ¼ 25 minutes;
range ¼ 10–30). SPC was provided for all patients
throughout their entire hospital stay, including the
period of time they were enrolled in the RCT. Aside
from not receiving DT, participants randomized to
SPC were provided regular assessment and manage-
ment by the entire multiprofessional team. Other
than the principal and secondary investigators, the
remaining members of the palliative care team
were not informed as to which patients were enrolled
in the study, or whether or not they received DT. This
reduced any potential for bias or alteration of care
based on knowledge of arm assignment. The princi-
pal and secondary investigators had limited clinical
contact with patients, given that the former worked
one day a week on the palliative care ward and the
latter was the chief nurse and had little direct patient
contact.
Dignity Therapy
DT is a brief psychotherapeutic intervention de-
signed to bolster a patient’s sense of meaning and
purpose in order to reinforce a continued sense of
worth, within a framework that is supportive, nur-
turing, and accessible. DT is based on an empirical
model of dignity in the terminally ill (Chochinov
et al., 2002). Various facets of the model have in-
formed key elements of this therapeutic modality,
likely accounting for its beneficial effects on patients
and families. The creation of a legacy document re-
flects the generativity component of the model, while
the questions focused on roles, accomplishments,
meaning, and purpose—and the opportunity to share
hopes, wishes, and life lessons with those they will
soon leave behind—are based on core dignity model
themes and subthemes (e.g., care tenor, continuity
of self, role preservation, and acceptance). Patients
enrolled in DT were guided by a trained therapist
(M.J.) to respond to questions about the aspects of
their lives they would most want their loved ones to
know about or remember.
Therapeutic sessions, lasting between 30 and 60
minutes, were offered at the patient’s bedside and au-
diotaped. Every tape-recorded session was erased af-
ter completion of the study protocol. Our study
utilized the DT question framework (see Table 1)
(Chochinov et al., 2005), as per previously published
trials. All DT sessions were conducted by the princi-
pal investigator (M.J.), who attended an interna-
tional DT workshop held in Canada hosted by the
developers of DT. All DT procedures were conducted
in accordance with those described and published
Table 1. Dignity therapy question protocol
Tell me a little about your life history, particularly the
parts that you either remember most or think are the
most important? When did you feel most alive?
Are there particular things that you would want your
family to know about you, and are there particular
things you would want them to remember?
What are the most important roles you have played in your
life (family roles, vocational roles, community service
roles, etc.)? Why were they so important to you, and
what do you think you accomplished within those roles?
What are your most important accomplishments, and what
do you feel most proud of?
Are there particular things that you feel still need to be
said to your loved ones, or things that you would want to
take the time to say once again?
What are your hopes and dreams for your loved ones?
What have you learned about life that you would want to
pass along to others? What advice or words of guidance
would you wish to pass along to your [son, daughter,
husband, wife, parents, other(s)]?
Are there words or perhaps even instructions you would
like to offer your family in order to provide them with
comfort or solace?
In creating this permanent record, are there other things
that you would like included?
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by Chochinov et al. (2005; 2011). A senior psychiatrist
(A.B.) acquainted with DT vetted randomly selected
DT transcripts in order to monitor fidelity and adher-
ence to the protocol.
Patients meeting the eligibility criteria and agree-
ing to participate in the study were asked to provide
written informed consent. Once patients completed
the baseline assessment, those randomized to DT
were provided with the standard framework of ques-
tions, thus giving them time to reflect upon and
shape their eventual responses. The taped DT ses-
sion was scheduled to take place within two or three
days. The therapeutic session was guided by the DT
framework. Once a taped session was complete, the
patient’s recorded dialogue was transcribed verbatim
and then edited and reshaped into a written narra-
tive over the course of the next two to three days.
The editing process was performed entirely by the
therapist (M.J.) and consisted of eliminating collo-
quialisms, nonstarters, and interruptions, and also
correcting chronological errors. Once this editing
process was complete, another session was arranged
as soon as possible where the therapist could read the
document to the patient, allowing for final editorial
corrections and revisions. The final version of the
generativity document was given to the patient, to
be distributed to individuals of their choosing.
Measures
The present paper reports on secondary outcomes:
DS, DfD, and SoD. The categorical and clinician rat-
ing diagnostic criteria for DS include all of the follow-
ing items: (1) an experience of emotional distress,
such as hopelessness or having lost meaning and
purpose in life; (2) attitudes of helplessness, failure,
and pessimism, and a loss of faith in a worthwhile fu-
ture; (3) a reduced ability to cope and respond flexi-
bly; (4) social isolation and deficient social support;
and (5) persistence of the abovementioned phenom-
ena for two or more weeks (Kissane et al., 2001). Kis-
sane and colleagues did not report any data on
validity and reliability. All five criteria had to be pre-
sent in order to diagnose DS and then study its prev-
alence.
In 1995, Chochinov et al. developed a global clini-
cal tool to rate patients’ DfD called the Desire for
Death Rating Scale (DDRS), but no data regarding
its reliability or validity were reported. Using open-
ended questions, the DDRS allows for clinician rat-
ings of DfD on a scale of 0 to 6. A score below 3 means
that a patient has no DfD, while patients with a seri-
ous or pervasive DfD had scores 4. To identify pa-
tients with DfD and its prevalence, we used a cutoff
score of 4 on the DDRS. The PDI (Chochinov
et al., 2008) was employed to assess SoD. This is a
25-item scale developed to provide a measure of dig-
nity-related distress and serve as a screening tool to
assess a broad range of issues that have been re-
ported to influence one’s sense of dignity. Each item
is rated on a 5-point scale, where 1 ¼ not a problem,
2 ¼ a slight problem, 3 ¼ a problem, 4 ¼ a major
problem, and 5 ¼ an overwhelming problem. The
value of Cronbach’s a for the PDI was 0.93, and its
test–retest reliability was r ¼ 0.85. Evidence for con-
current validity was reported by way of significant
associations between PDI factors and concurrent
measures of distress (Chochinov et al., 2008).
All the measurements taken in our study were as-
sessed at baseline (T1) and at day 4 (T2) post-DT, as
per the study protocol.
Statistical Analysis
We compared continuous variables and ordinal rat-
ing scales using Mann–Whitney nonparametric stat-
istical tests, while Fisher’s exact test was employed
for independent group comparisons (DT vs. SPC),
and McNemar’s test was utilized for paired compari-
sons between each timepoint (T2 and baseline)
within each study group. The criterion for statistical
significance was set at p , 0.05 in a two-tailed test.
The statistical analysis was applied to all patients
who had at least one complete evaluation at any
given follow-up point.
RESULTS
The summary demographic and illness data for both
groups are presented in Table 2. There were no differ-
ences between the two groups on baseline character-
istics. Over a 36-month period, 150 patients were
admitted to the palliative care ward. A total of 92
were assessed for eligibility, 80 of whom were ran-
domized (41 to DT and 39 to SPC). Some 12 patients
were not randomized as a result of not meeting the
inclusion criteria (n ¼ 8) and declining to participate
(n ¼ 4). After randomization, one patient died before
receiving DT and another clinically deteriorated rap-
idly; 10 patients were lost to follow-up (as a result of
death, clinical deterioration, or declining further par-
ticipation) at T2 (DT n ¼ 6; SPC n ¼ 4) (see the CON-
SORT diagram reported elsewhere) (Julia˜o et al.,
2013a; 2014). The mean survival time was 25.4
days (DT ¼ 27.4; SPC ¼ 26.8; p ¼ 0.453).
Demoralization Syndrome
As previously reported, the prevalence of DS was
52.5% (Julia˜o et al., 2016). No statistically significant
differences were found between the two study groups
at baseline with respect to prevalence of DS ( p ¼
0.901). Within the DT group, DS shifted from 53.9%
Julia˜o et al.4
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at baseline to 12.1% post-intervention ( p ¼ 0.002),
while in the SPC group it shifted from 51.2 to
60.0% ( p ¼ 0.343) (Table 3). Of the participants in
the DT group who had DS at baseline, 82.4% no lon-
ger met the criteria for DS post-intervention. Of the
DT participants who did not have DS at baseline,
6.2% did so post-intervention ( p ¼ 0.008). Within
the control group, of the participants who had DS
at baseline, 18.6% no longer met the criteria for DS
post-intervention. Of those in the SPC group who
Table 2. Summary characteristics of participants at baseline (N ¼ 80)
Control group (n ¼ 39) DT group (n ¼ 41) Value of p**
Gender, n (%)
Male 18 (43.9) 19 (48.7) 0.823
Female 23 (56.1) 20 (51.3)
Age, years
Mean (SD) 66.1 (12.9), range ¼ 28–90
≤65 21 (51.2) 20 (51.3) 1.000
.65 20 (48.8) 19 (48.7)
Race/ethnicity, n (%)
Caucasian 38 (95.0) 37 (94.9) 1.000
African 2 (5.0) 2 (5.1)
Marital status, n (%)
Single 9 (21.9) 6 (15.4) 0.719
Married/common law 14 (34.2) 18 (46.2)
Divorced/separated 7 (17.1) 5 (12.8)
Widowed 11 (26.8) 10 (25.6)
Education, n (%)
Knows how to read and write
(without instruction)
2 (4.9) 2 (5.1) 0.844
Primary school 16 (39.2) 12 (30.8)
High school 12 (29.3) 15 (38.5)
Licensure 11 (26.8) 10 (25.6)
Religion, n (%)
Catholic 35 (85.4) 33 (84.6) 1.000
Other 6 (14.6) 6 (15.4)
Diagnosis, n (%)
Cancer* 37 (94.9) 37 (90.2) 0.676
Noncancer† 2 (5.1) 4 (9.8)
Time since diagnosis,‡ n (%)
1 year 2 (4.9) 4 (10.3) 0.103
1–2 years 13 (31.7) 5 (12.8)
≥2 years 26 (63.4) 30 (76.9)
Psychiatric drugs, n (%)
Antidepressants 22 (56.4) 24 (58.5) 1.000
Anxiolytics 24 (61.5) 27 (65.9) 1.000
Neuroleptics 6 (15.4) 1 (2.4) 0.520
Anticonvulsants 17 (41.5) 22 (56.4) 0.263
Palliative Performance Scale§
57.1 (17.5), range ¼ 30–90
Mean (SD) 57.6 (18.2) 56.7 (16.9) 0.821
Mini-Mental State
24.4 (1.9), range ¼ 20–28
Mean (SD) 24.1 (2.0) 24.7 (1.9) 0.212
DT ¼ dignity therapy; SD ¼ standard deviation.
*Lung (n ¼ 10), ovarian (n ¼ 5), breast (n ¼ 4), glioblastoma (n ¼ 4), uterus (n ¼ 4); tongue (n ¼ 3), bladder (n ¼ 2);
caecum (n ¼ 2), endometrium (n ¼ 2), esophagus (n ¼ 2), larynx (n ¼ 2), stomach (n ¼ 2), prostate (n ¼ 2) unknown
primary cancer, (n ¼ 2), chronic myeloid leukemia (n ¼ 1), dorsal neurinoma (n ¼ 1), glioma (n ¼ 1), melanoma (n ¼ 1),
neoplasm of the nose (n ¼ 1), pancreas (n ¼ 1), small bowel neuroendocrine tumor (n ¼ 1), vascular arterial cancer
(n ¼ 1).
† Lateral amyotrophic sclerosis (n ¼ 2), trigeminal neuralgia (n ¼ 1).
‡ Based on medical records or patient information.
§ Palliative Performance Scale scores: 100% ¼ healthy, 0% ¼ dead.
** Fisher’s exact test, with the exception of the Palliative Performance Status and the Mini-Mental State, where the
Mann–Whitney test was used.
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did not have DS at baseline, 38.8% met the criteria
for DS post-intervention ( p ¼ 0.205).
DT was associated with a significant decrease in
the incidence of DS compared to SPC (DT DS
prevalence ¼ 12.1%; SPC DS prevalence ¼ 60.0%;
p , 0.001) (Table 3).
Desire for Death
The prevalence of DfD (DDRS  4) for the entire co-
hort was 20.0% (Julia˜o et al., 2013b). There were no
statistically significant differences between the two
study groups at baseline with respect to DfD ( p ¼
0.582).
Within the DT group, the prevalence of DfD
shifted from 23.0% at baseline to 0% post-interven-
tion ( p ¼ 0.023). On the other hand, the prevalence
of DfD in the SPC group shifted from 17.0% at base-
line to 14.3% post-intervention ( p ¼ 1.0) (Table 3). Of
those patients in the DT group with a DfD at base-
line, none had a DfD post-intervention. On the other
hand, no patient shifted from not having a DfD at
baseline to a significant DfD post-DT ( p ¼ 0.015).
Within the control group, of the participants who
had a DfD at baseline, 66.7% had no desire for death
upon follow-up; and 10.3% moved from not having a
DfD at baseline to having a desire for death at fol-
low-up ( p ¼ 1.0).
DT was associated with a significant decrease in
DfD prevalence (DT DfD prevalence ¼ 0%; SPC
DfD prevalence ¼ 14.3%; p ¼ 0.054) (Table 3).
Sense of Dignity
Of the 25 PDI questions, only 9 had a mean score ,3,
meaning that these patients did not identify that is-
sue as being problematic (Chochinov et al., 2008).
Most responses to the PDI questions at baseline
(64%) had an average score 3, revealing intense
dignity-related suffering (Chochinov et al., 2008).
Patients allocated to the DT group showed a statis-
tically significant decrease in all PDI questions ex-
cept for cognitive capacity, meaningful life, and
healthcare support. Patients allocated to the control
group showed a statistically significant decrease in
only five PDI questions, particularly related to bodily
functions/independence, physical symptoms, anxi-
ety, sense of worth/value, and healthcare support.
Compared with participants allocated to the control
group, those who received DT showed a statistically
significant reduction on 19 of 25 PDI items (with the
exception of items 4, 9, 15, 21, 22, and 25 [Table 4]).
DISCUSSION
To the best of our knowledge, this is the first RCT to
study the efficacy of DT for demoralization and DfD
in terminally ill patients. It is also the first Portuguese
study to look at the effect of this brief psychotherapeu-
tic intervention on sense of dignity and sources of dig-
nity-related distress. As previously reported by our
research group, the patients in this RCT had high lev-
els of psychosocial distress at baseline—namely, de-
pression and anxiety (Julia˜o et al., 2013a; 2014).
This cohort of patients also experienced high levels
of DS, DfD, and dignity-related distress.
DT appeared to significantly decrease DS, DfD,
and SoD—that is, patients who received DTwere sig-
nificantly more likely than SPC patients to experi-
ence significant reductions in DS and DfD, along
with improvement of their SoD. These results indi-
cate that DT is an effective psychotherapeutic inter-
vention for those dimensions of the end-of-life
experience.
Many underlying causes could explain the mecha-
nisms by which the DT reduces patient distress. We
think that patients who engage in DT are better
able to move beyond their sadness and vital suffer-
ing, to an activity imbued with meaning and purpose.
In addition, the end-of-life period also offers opportu-
nities for personal growth and deepening of relation-
ships, and this might also be an important source of
DT’s efficacy.
Table 3. Efficacy of DTwith respect to demoralization syndrome and desire for death, within and between
study groups
Baseline (%) Post-intervention (%) Value of p**
Demoralization syndrome DT group 53.9 12.1 0.002 (within effect)
p value* 0.901 (between effect) ,0.001 (between effect)
Control group 51.2 60.0 0.343 (within effect)
Desire for death DT group 23.0 0 0.023 (within effect)
p value* 0.582 (between effect) 0.054 (between effect)
Control group 17.0 14.3 1.0 (within effect)
DT ¼ dignity therapy.
* Fisher’s exact test.
** McNemar’s exact test.
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According to de Figueiredo (1993), the key ele-
ments of DS include marked incompetence, a pro-
found inability to express feelings and develop
tasks properly when confronted with illness, leading
to a state of inability, uncertainty, profound lethargy,
and doubts concerning the future. According to the
author, demoralized patients lose their cognitive
mapping, plunging into vital incompetence. Perhaps
DT influences DS by calling upon patients to actively
engage in the retelling of their stories and the crea-
tion of a legacy document. This task requires that
they not only summarize certain aspects of their
life, but that they do so in the service of those they
are about to leave behind. This future orientation of
DT sees demoralized patients, who have lost hope
in the future, having to invest in others who will out-
live them so that they can take their words into a fu-
ture the patients will no longer be a part of. Thus, DT
encourages demoralized and emotionally lethargic
patients to revive, to regain some of their inner
strength in order to engage in and enable the creation
of their generativity document. It demands a future
orientation, which sees participants achieve mastery,
by way of creating a tangible product that takes them
beyond their present circumstances and thus reduces
their self-perception of incompetence. As one patient
put it, “Yes, I can achieve this. It’s possible, and I can
do it and believe in something more than my empty
and disease-full present.”
DT was effective in reducing a desire for death,
both within the intervention group ( p ¼ 0.023) as
well as compared to the control group ( p ¼ 0.054).
These results suggest that DT might reduce requests
for a hastened death in patients approaching the end
of their lives. Dignity therapy was able to eliminate
DfD in every participant in the DT group who had
originally scored above the critical DfD threshold cri-
terion separating them from those without a desire to
Table 4. Differences in PDI item scores between T1 and T2, comparing DT and SPC
PDI questions
DT group Control group
Mean (SD) Median
p
value* Mean (SD) Median
1. Not being able to carry out tasks associated with daily
living
20.70 (1.16) 21.00 0.002 0.26 (1.29) 0.00
2. Not being able to attend to my bodily functions
independently
20.73 (1.18) 0.00 0.000 0.41 (1.10) 0.00
3. Experiencing physically distressing symptoms 21.58 (1.60) 22.00 0.006 20.53 (1.33) 0.00
4. Feeling that how I look to others has changed significantly 20.88 (1.22) 21.00 0.127 20.24 (1.50) 0.00
5. Feeling depressed 21.09 (1.49) 21.00 0.000 0.09 (1.03) 0.00
6. Feeling anxious 20.94 (1.32) 21.00 0.000 0.33 (.85) 0.00
7. Feeling uncertain about my illness and treatment 21.24 (1.20) 21.00 0.000 20.03 (1.11) 0.00
8. Worrying about my future 21.48 (1.35) 22.00 0.000 0.12 (0.81) 0.00
9. Not being able to think clearly 20.15 (1.25) 0.00 0.070 0.35 (0.95) 0.00
10. Not being able to continue with my usual routines 20.85 (1.28) 21.00 0.004 20.03 (0.90) 0.00
11. Feeling like I am no longer who I was 21.82 (1.40) 22.00 0.000 20.15 (1.28) 0.00
12. Not feeling worthwhile or valued 21.30 (1.76) 21.00 0.014 20.38 (1.07) 0.00
13. Not being able to carry out important roles 21.18 (1.51) 21.00 0.021 20.29 (1.45) 0.00
14. Feeling that life no longer has meaning or purpose 21.73 (1.55) 22.00 0.000 0.00 (1.41) 0.00
15. Feeling that I have not made a meaningful and lasting
contribution during my lifetime
20.21 (1.47) 0.00 0.524 0.06 (1.01) 0.00
16. Feeling I have ‘unfinished business 21.27 (1.59) 21.00 0.011 20.32 (1.32) 0.00
17. Concern that my spiritual life is not meaningful 20.78 (1.29) 0.00 0.021 20.12 (0.77) 0.00
18. Feeling that I am a burden to others 21.03 (1.21) 21.00 0.002 20.15 (1.16) 0.00
19. Feeling that I don’t have control over my life 21.21 (1.39) 21.00 0.000 0.06 (1.04) 0.00
20. Feeling that my illness and care needs have reduced my
privacy
21.03 (1.31) 21.00 0.001 0.03 (0.97) 0.00
21. Not feeling supported by my community of friends and
family
20.56 (1.32) 0.00 0.249 20.12 (0.78) 0.00
22. Not feeling supported by my healthcare providers 20.12 (0.78) 0.00 0.175 20.26 (0.79) 0.00
23. Feeling like I am no longer able to mentally “fight” the
challenges of my illness
21.30 (1.40) 21.00 0.000 0.15 (0.99) 0.00
24. Not being able to accept the way things are 21.52 (1.42) 21.00 0.000 20.03 (0.97) 0.00
25. Not being treated with respect or understanding by others 20.58 (1.52) 0.00 0.206 20.15 (0.61) 0.00
DT ¼ dignity therapy; SD ¼ standard deviation; SPC ¼ standard palliative care.
Bold ¼ significant values.
* Mann–Whitney test.
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die. Patients allocated to the control group showed no
significant change in their desire to die sooner ( p ¼
1.0), which means that the multidisciplinary inter-
vention was not able to reduce their DfD.
Again, there are many possible explanations for
how DT might affect a patient’s DfD. By focusing on
the personal narrative and experiencing a therapeu-
tic encounter that includes active listening, DT may
reinforce a sense of meaning, of being valued, and
of being important, despite the challenges caused
by one’s illness, therefore helping patients to relin-
quish a death-hastening stance. As reported else-
where (Chochinov et al., 1995; Julia˜o et al., 2013a),
DfD is fluctuant and can be influenced by a therapeu-
tic stance comprised of compassion and unwavering
support in the face of suffering.
Aside from higher levels of anxiety and depres-
sion, the participants in our study also experienced
more pronounced dignity-related distress compared
with those reported in the prior DT RCT (Chochinov
et al., 2011). Only 9 of 25 PDI items had a mean score
,3, indicating an absence of significant dignity-re-
lated distress. The associations among depression,
anxiety, and dignity-related distress have been well-
documented (Chochinov et al., 2011; Julia˜o, 2014).
Based on our findings, DT appears to be an effective
way to bolster dignity by way of decreasing dignity-
related distress. DT outperformed SPC in mitigating
suffering based on “dependency” (PDI items 1, 2, 10,
18, and 20), “existential suffering” (4, 8, 11, 12, 14, 15,
16, 17, and 24), and “control” (13, 19, and 23).
A factor analysis performed by Hack et al. (2010)
within a cohort of patients with end-stage cancer
showed that hopelessness, privacy boundaries, and
intimate daily hygiene activities (including diaper
changes and assisted baths) were most highly associ-
ated with SoD. This offers guidance to caregivers and
health professionals in pursuit of providing dignity-
conserving care for patients nearing death (Chochi-
nov, 2002). Dignity therapy is anchored in the
essential premise of respect. Within the very medi-
cally oriented world, DT therapists create private
and hopeful moments wherein patients can feel val-
ued and return to looking at the world and those
who provide them care as being imbued with human-
ity, with compassion, thus enhancing their experi-
ence of care, despite the challenges of relinquishing
privacy and accepting the intimate dependencies of
care. DT allows patients to reclaim a sense of control,
even if for a brief period, as they approach death. As
one patient put it,
I thought life had reached an end without yet hav-
ing ended. I belonged to a strange sensation that I
didn’t have any control over my daily activities.
[The] world’s adversity took control over me. This
disease gave me the false idea that it ruled me.
It’s not true. I can’t do my hygiene and other regu-
lar tasks anymore, but I’m capable of producing in-
credible things—like the legacy document—far
beyond my ill body. I can create beyond my bound-
aries [and] dependencies, and I discovered that
dignity therapy is a way to achieve that.
LIMITATIONS OF THE STUDY
Like any study, ours had its limitations. Our sample
consisted primarily of older patients. As such, the in-
fluence of DT within younger cohorts remains uncer-
tain and deserves further examination. Despite a
relatively small sample size, we were able to detect
significant differences between and within groups,
indicating clinically important benefits in terms of
the psychosocial dimensions of end-of-life suffering.
The majority of our participants had end-stage ma-
lignancies. Our future research will aim to explore
the utility of DT in other terminal conditions, such
as end-stage organ failure. In the present trial, DT
was performed exclusively by one therapist (M.J.),
who carefully followed the DT protocol (Chochinov
et al., 2005; Chochinov, 2011) and was trained by
the originators of this therapeutic approach. He
was not and could not be blinded to study arm assign-
ment, which raises the question of potential bias.
However, patients in both groups received equal-
quality palliative care (SPC), and all the evaluations,
treatment plans, and direct interventions were car-
ried out by the entire multidisciplinary team.
It is important to place the findings of our study
within the context of Portuguese culture and reli-
gion, especially with respect to views regarding suf-
fering, death, and dying. Most Portuguese are
Catholics and accept the end of life and its related
suffering as beyond question and in the “hands of
God.” In Portugal, particularly among the elderly,
there has traditionally been great reticence to ex-
press feelings regarding physical and psychological
discomfort. Consequently, healthcare providers fre-
quently avoid engaging in conversations pertaining
to the topics of death and dying. While this might pre-
sent a challenge to implementing DT, it is notable
that most patients approached to participate in our
study did so (only 4 out of the 92 patients assessed
for eligibility declined to participate), and they bene-
fited from the opportunity to share their reflections,
hopes, and wishes for the loved ones they were about
to leave behind. This could affect the way people are,
or are not, accepting of death, and perhaps even the
way that death anxiety plays itself out in Portuguese
society. Again, having a therapist who offers an inter-
vention based on life’s positive aspects, achievements,
human relationships, and wishes that will be collected
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https://doi.org/10.1017/S1478951516001140
Downloaded from https:/www.cambridge.org/core. Kainan University, on 10 Feb 2017 at 11:57:30, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
in a legacy document might give terminally ill people a
chance to reconnect with something more simple and
pure, higher and more meaningful, that speaks for
love, caring for others, and not for guilt or punish-
ment, thus alleviating some of the ancient and
heavy-laden Catholic view of death.
Another disadvantage that must be acknowledged
is that assessments were performed at baseline and
only four days after the intervention. No conclusions
can therefore be drawn about the time stability of the
variables.
DT provided beneficial effects in the psychological
dimensions of the distress experienced by patients
near the end of life. While further research on DT is
warranted, mounting evidence suggests that this
unique psychotherapeutic approach is an important
tool that should be included in the clinical care of ter-
minally ill patients and their families.
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